Fennec Pharmaceuticals Inc. (FENC)
NASDAQ·Healthcare·Biotechnology
$10.05
+4.74%
Mkt Cap $209.10M
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$17.00
Range $16.00 – $18.00
Implied Upside
+69.2%
Consensus $17.00 vs current $10.05
NASDAQ·Healthcare·Biotechnology
$10.05
+4.74%
Mkt Cap $209.10M
No recent rating data.
Price Target (9 analysts)
$17.00
Range $16.00 – $18.00
+69.2%
Consensus $17.00 vs current $10.05